- DatesNovember 2024 to 30 October 2027.
- SponsorMedical Research Council (MRC), part of UK Research and Innovation (UKRI)
- Funded£1,573,807 (UKRI/ISPF UK award; approximately £3 million total UK–China programme funding)
- PartnersUK: University of Exeter; UK Centre for Ecology and Hydrology (UKCEH); Queen's University Belfast. China: Research Centre for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences (CAS); China National Centre for Food Safety Risk Assessment (CFSA); CAS Institute of Urban Environment (IUE); Zhejiang Provincial Centre for Disease Control and Prevention (ZJCDC); Anhui Agricultural University (AHAU).
This UK-China One Health project investigates how multidrug resistance (MDR) evolves, is selected and is transmitted across human, animal and environmental microbiomes. It combines comparative metagenomics and genomics, computational and machine-learning approaches, experimental evolution, and wastewater-based epidemiology to identify drivers of MDR and distinguish resistance genes under active selection. The project will integrate selection, phenotype and gene co-occurrence data into a new AMR risk-ranking framework. Âé¶¹Íø leads development of low-cost field diagnostics, including paper-based CRISPR/Cas assays and SERS-based detection, validated against high-throughput SmartChip data and tested in wastewater and environmental settings in the UK and China.
Impact and findings
The project has established optimised RPA–CRISPR assay conditions for the rapid detection of antimicrobial resistance genes across different risk categories. By incorporating paraffin as a thermally activated switch, we have developed a partially enclosed reaction format that reduces handling steps and enables results to be obtained within 20 minutes. Multiphysics flow modelling has also been applied to investigate heat transfer, reagent movement and reaction behaviour throughout the detection process. These findings provide a strong technical basis for improving assay robustness, supporting future device integration and facilitating the transfer of the sensing platform into scalable engineering and field-deployable applications.
Progress update
The project has established optimised RPA–CRISPR assay conditions to support rapid detection of antimicrobial resistance markers relevant to multidrug resistance (MDR) surveillance. By incorporating paraffin as a thermally activated switch, a partially enclosed reaction format has been developed to reduce handling steps and enable results within approximately 20 minutes. Multiphysics modelling has also been used to investigate heat transfer, reagent movement and reaction behaviour within the system. These findings provide a technical foundation for adapting the platform to priority MDR markers identified through the wider One Health programme and for subsequent integration into portable, field-deployable sensing formats for wastewater and environmental AMR monitoring.